The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Kane Biotech Inc

Venture: KNE
Delayed quote

$0.04

Today's change-0.01 -12.50%
Updated November 28 2:12 PM EST. Delayed by at least 15 minutes.
 

Kane Biotech Inc

Venture: KNE
Delayed quote

$0.04

Today's change-0.01 -12.50%
Updated November 28 2:12 PM EST. Delayed by at least 15 minutes.

Kane Biotech Inc crosses below 20-day moving average

Kane Biotech Inc closed sharply lower Friday, dropping $0.01 or 12.50% to $0.04 and crossing below its 20-day moving average. Over the last five days, shares have gained 16.67%, but are down 58.82% for the last year to date. Shares have underperformed the S&P TSX by 63.61% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated November 28 2:12 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-719.94%

Kane Biotech Inc has a net profit margin of -719.94%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0------
Total cost of revenue0------
Total operating expense0000
Selling / general / administrative0000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets0000
Other--------
Income before tax0-100
Income after tax0-100
Income tax, total0000
Net income0-100
Total adjustments to net income--------
Net income before extra. items0-100
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-100
Inc. avail. to common incl. extra. items0-100
Diluted net income0-100
Dilution adjustment--------
Diluted weighted average shares82818179
Diluted EPS excluding extraordinary itemsvalue per share0.00-0.010.000.00
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.00-0.010.000.00